{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:26:24Z","timestamp":1786119984718,"version":"build-2736575974"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1097\/jcp.0b013e3182196e50","type":"journal-article","created":{"date-parts":[[2011,4,29]],"date-time":"2011-04-29T04:51:12Z","timestamp":1304052672000},"page":"385-387","source":"Crossref","is-referenced-by-count":19,"title":["Amitriptyline and Prochlorperazine Inhibit Proinflammatory Mediator Release From Human Mast Cells"],"prefix":"10.1097","volume":"31","author":[{"given":"Anthony","family":"Clemons","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalini","family":"Vasiadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duraisamy","family":"Kempuraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taxiarchis","family":"Kourelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Vandoros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theoharis C.","family":"Theoharides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"suppl 1","key":"R1-27-20210128","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/1471-244X-9-S1-S1","article-title":"Chronic fatigue syndrome: aetiology, diagnosis and treatment.","volume":"9","author":"Avellaneda","year":"2009","journal-title":"BMC Psychiatry"},{"issue":"4","key":"R2-27-20210128","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S1521-6942(03)00033-0","article-title":"Chronic diffuse musculoskeletal pain, fibromyalgia and co-morbid unexplained clinical conditions.","volume":"17","author":"Aaron","year":"2003","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"10","key":"R3-27-20210128","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1517\/14656560902988510","article-title":"Pharmacological treatment of chronic fatigue syndrome: focusing on the role of antidepressants.","volume":"10","author":"Pae","year":"2009","journal-title":"Expert Opin Pharmacother"},{"key":"R4-27-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2003.10.041","article-title":"Critical role of mast cells in inflammatory diseases and the effect of acute stress.","volume":"146","author":"Theoharides","year":"2004","journal-title":"J Neuroimmunol"},{"issue":"6","key":"R5-27-20210128","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/01.jcp.0000193483.89260.a7","article-title":"Chronic fatigue syndrome, mast cells, and tricyclic antidepressants.","volume":"25","author":"Theoharides","year":"2005","journal-title":"J Clin Psychopharmacol"},{"key":"R6-27-20210128","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0006-8993(76)90322-X","article-title":"Histidine decarboxylase and histamine in discrete nuclei of rat hypothalamus and the evidence for mast cells in the median eminence.","volume":"118","author":"Pollard","year":"1976","journal-title":"Brain Res"},{"key":"R7-27-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-8993(99)01855-7","article-title":"Morphological and functional demonstration of rat dura mast cell-neuron interactions in vitro and in vivo.","volume":"849","author":"Rozniecki","year":"1999","journal-title":"Brain Res"},{"key":"R8-27-20210128","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.tips.2004.09.007","article-title":"Mast cells as targets of corticotropin-releasing factor and related peptides.","volume":"25","author":"Theoharides","year":"2004","journal-title":"Trends Pharmacol Sci"},{"key":"R9-27-20210128","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1124\/jpet.102.038497","article-title":"Corticotropin-releasing hormone (CRH) and brain mast cells regulate blood-brain-barrier permeability induced by acute stress.","volume":"303","author":"Esposito","year":"2002","journal-title":"J Pharmacol Exp Therap"},{"key":"R10-27-20210128","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0145-2126(02)00343-0","article-title":"Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma\/leukemia; activation following aggregation of FcepsilonRI or FcgammaRI.","volume":"27","author":"Kirshenbaum","year":"2003","journal-title":"Leuk Res"},{"issue":"2","key":"R11-27-20210128","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1001\/jama.2008.944","article-title":"Treatment of fibromyalgia syndrome with antidepressants: a meta-analysis.","volume":"301","author":"Hauser","year":"2009","journal-title":"JAMA"},{"key":"R12-27-20210128","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/297229a0","article-title":"Differential release of serotonin and histamine from mast cells.","volume":"297","author":"Theoharides","year":"1982","journal-title":"Nature"},{"issue":"1","key":"R13-27-20210128","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0014-2999(92)90579-S","article-title":"Amitriptyline, desipramine, cyproheptadine and carbamazepine, in concentrations used therapeutically, reduce kainate- and N-methyl-D-aspartate-induced intracellular Ca2+ levels in neuronal culture.","volume":"219","author":"Cai","year":"1992","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"R14-27-20210128","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF01966694","article-title":"Inhibition of histamine release and ionophore-induced calcium flux in rat mast cells by lidocaine and chlorpromazine.","volume":"9","author":"Johnson","year":"1979","journal-title":"Agents Actions"},{"issue":"2","key":"R15-27-20210128","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1476-5381.1989.tb11984.x","article-title":"Divalent cation dependence of the inhibition by phenothiazines of mediator release from mast cells.","volume":"97","author":"Peachell","year":"1989","journal-title":"Br J Pharmacol"},{"key":"R16-27-20210128","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1146\/annurev.immunol.21.120601.141025","article-title":"Mast cells as \"tunable\" effector and immunoregulatory cells: recent advances.","volume":"23","author":"Galli","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"R17-27-20210128","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.1073\/pnas.1000803107","article-title":"IL-33 augments substance P-induced VEGF secretion from human mast cells and is increased in psoriatic skin.","volume":"107","author":"Theoharides","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"R18-27-20210128","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1128\/CDLI.12.1.52-55.2005","article-title":"Spinal fluid abnormalities in patients with chronic fatigue syndrome.","volume":"12","author":"Natelson","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"key":"R19-27-20210128","first-page":"615","article-title":"Severity of symptom flare after moderate exercise is linked to cytokine activity in chronic fatigue syndrome.","volume":"47","author":"White","year":"2010","journal-title":"Psychophysiology"},{"key":"R20-27-20210128","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1479-5876-7-96","article-title":"Plasma cytokines in women with chronic fatigue syndrome.","volume":"7","author":"Fletcher","year":"2009","journal-title":"J Transl Med"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00004714-201106000-00027","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T19:30:08Z","timestamp":1786044608000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004714-201106000-00027"}},"subtitle":["Possible Relevance to Chronic Fatigue Syndrome"],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e3182196e50","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}